Table 3.
Genotype frequencies of serpin family E member 1 (SERPINE1) -844 and -675 polymorphisms in patients with chronic obstructive pulmonary disease (COPD; n = 140) and healthy smoking controls (n = 100).
| Study group |
SERPINE1 -844 A/G |
SERPINE1 -675 4G/5G |
||||
|---|---|---|---|---|---|---|
| A/A | A/G | G/G | 4G/4G | 4G/5G | 5G/5G | |
| COPD | 18 (12.9) | 69 (49.3) | 53 (37.9) | 55 (39.3) | 65 (46.4) | 20 (14.3) |
| Control | 13 (13.0) | 51 (51.0) | 36 (36.0) | 26 (26.0) | 55 (55.0) | 19 (19.0) |
| Statistical significance | χ2 = 0.09 | NS | χ2 = 4.71 | NS | ||
Data presented as n (%) prevalence.
NS, no statistically significant between-group difference (P > 0.05; χ2-test).